Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes
Discovering the function of a gene requires cloning a DNA sequence and expressing it. Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck. Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics.
“We think that the rapid, affordable, and high-throughput cloning of proteins and other genetic elements will greatly accelerate biological research to discover functions of molecules encoded by genomes and match the pace at which new genome sequencing data is coming out,” said Biju Parekkadan, an associate professor in the Department of Biomedical Engineering at Rutgers University-New Brunswick.
In a study published online today in the journal Nature Biomedical Engineering, the researchers showed that their technology – LASSO (long-adapter single-strand oligonucleotide) probes – can capture and clone thousands of long DNA fragments at once.
As a proof-of-concept, the researchers cloned more than 3,000 DNA fragments from E. coli bacteria, commonly used as a model organism with a catalogued genome sequence available.
“We captured about 95 percent of the gene targets we set out to capture, many of which were very large in DNA length, which has been challenging in the past,” Parekkadan said. “I think there will certainly be more improvements over time.”
They can now take a genome sequence (or many of them) and make a protein library for screening with unprecedented speed, cost-effectiveness and precision, allowing rapid discovery of potentially beneficial biomolecules from a genome.
In conducting their research, they coincidentally solved a longstanding problem in the genome sequencing field. When it comes to genetic sequencing of individual genomes, today’s gold standard is to sequence small pieces of DNA one by one and overlay them to map out the full genome code. But short reads can be hard to interpret during the overlaying process and there hasn’t been a way to sequence long fragments of DNA in a targeted and more efficient way. LASSO probes can do just this, capturing DNA targets of more than 1,000 base pairs in length where the current format captures about 100 base pairs.
The team also reported the capture and cloning of the first protein library, or suite of proteins, from a human microbiome sample. Shedding light on the human microbiome at a molecular level is a first step toward improving precision medicine efforts that affect the microbial communities that colonize our gut, skin and lungs, Parekkadan added. Precision medicine requires a deep and functional understanding, at a molecular level, of the drivers of healthy and disease-forming microbiota.
Today, the pharmaceutical industry screens synthetic chemical libraries of thousands of molecules to find one that may have a medicinal effect, said Parekkadan, who joined Rutgers’ School of Engineering in January.
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” he said. “This could transform pharmaceutical drug discovery into biopharmaceutical drug discovery with much more effort.”
The next phase, which is underway, is to improve the cloning process, build libraries and discover therapeutic proteins found in our genomes, Parekkadan said.
The Latest on: Precision medicine
[google_news title=”” keyword=”precision medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Precision Medicine Can Be Integrated Into Routine Cancer Careon February 1, 2023 at 10:59 pm
The integration of precision medicine into routine cancer care is feasible and has clinical utility, according to a study published online Jan. 12 in JCO Precision Oncology. Rachel B. Keller, Ph.D., ...
- Precision Oncology Data Registry May Perpetuate Health Disparitieson February 1, 2023 at 9:00 am
Researchers have uncovered racial and ethnic disparities in a widely used precision oncology data registry, which may impact study validity and generalizability.
- Mediclinic Southern Africa Takes A Bet On Precision Medicine With Acquisition Of Artisan Biomedon February 1, 2023 at 5:06 am
This acquisition of Artisan Biomed launches Mediclinic Precise, a bundle of DNA-based diagnostic and clinical interpretation services offering a new approach to healthcare, based on an individual’s ...
- The Future Of Precision Medicine - Liquid Biopsy Market: What's The Future Of Cancer Screening?on February 1, 2023 at 4:46 am
Liquid Biopsy Market Liquid Biopsy Market size is expected to be worth around USD 28,308 million by 2032 from USD 7,979.00 million in 202 ...
- PTSD Study Uses Precision Medicine Tech from AiCureon January 31, 2023 at 8:55 am
Rich Christie, MD, PhD, Chief Medical Officer at AiCure discusses the use of the company's technology in a clinical trial for PTSD.
- Global Precision Medicine Market Competitive Landscape and Trends - By The Business Research Companyon January 31, 2023 at 4:37 am
According to The Business Research Company's Precision Medicine Global Market Report 2023, the competitive landscape of global precision medicine market is fairly fragmented, with a large number of ...
- Sidra Medicine takes part at Precision Medicine World Conferenceon January 30, 2023 at 11:18 am
A team of researchers and physicians from Sidra Medicine, a member of Qatar Foundation, were at Precision Medicine World Conference (PMWC 2023) in California last week to ...
- Precision Medicine Diagnostics Market: 2023 Latest Research Flourishing Across Regions by Future Trends and Hike in Revenue Forecast by 2027on January 30, 2023 at 2:05 am
Precision Medicine Diagnostics Market” Qualitative Research Report 2023-2027 offers an crucial insights into key ...
- Precision Medicine Market Size And Opportunities for New Players, Forecast from 2023 To 2028 with Top Countries Dataon January 27, 2023 at 3:24 pm
Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Precision Medicine ...
- Precision Medicineson January 24, 2023 at 7:16 pm
Precision medicine is a medical approach that uses an individual’s genetic, environmental, and lifestyle information to inform the diagnosis, treatment, and prevention of diseases. It is a way ...
via Google News and Bing News